Suppr超能文献

住院3个月后肺栓塞对COVID-19健康结局的影响。

The impact of pulmonary embolism on health outcomes of COVID-19 at 3 months after hospitalization.

作者信息

Visser Chantal, Berentschot Julia C, de Jong Cindy M M, Antoni M Louisa, Bek L Martine, van den Berg-Emons Rita J G, van den Borst Bram, Ten Cate Hugo, Ten Cate-Hoek Arina J, Braeken Dionne C W, Geelhoed J J Miranda, Heijenbrok-Kal Majanka H, van Kuijk Sander M J, Kroft Lucia J M, Leentjens Jenneke, Roukens Anna H E, Cannegieter Suzanne C, Klok Frederikus A, Kruip Marieke J H A, Hellemons Merel E

机构信息

Department of Hematology, Erasmus MC, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.

Department of Respiratory Medicine, Erasmus MC, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.

出版信息

Res Pract Thromb Haemost. 2024 Sep 16;8(7):102573. doi: 10.1016/j.rpth.2024.102573. eCollection 2024 Oct.

Abstract

BACKGROUND

COVID-19 patients frequently experience pulmonary embolism (PE), but its long-term consequences remain uncertain.

OBJECTIVES

To assess the impact of PE in COVID-19 patients on health outcomes at 3 months after hospitalization.

METHODS

In this multicenter cross-sectional study, we aggregated data from existing databases to evaluate the impact of PE on health outcomes at 3 months after hospitalization. We assessed 1) questionnaires on health-related quality of life (5-level EuroQol 5-dimensional questionnaire [EQ-5D-5L] questionnaire), anxiety, depression, cognitive failure, and posttraumatic stress disorder; 2) pulmonary function tests (diffusing capacity of the lungs for carbon monoxide [DLCO] and spirometry); and 3) radiological abnormalities. We developed 3 models to assess the association between PE and the EQ-5D-5L index and the percentage of predicted DLCO (DLCO%): a crude model (model 1), adjusted for age, sex, and presence of comorbidities (model 2), and model 2 additionally adjusted for intensive care unit admission (model 3).

RESULTS

We included 465 patients who had been hospitalized for COVID-19, of whom 102 (21.9%) had developed a PE during admission. Patients with PE had poorer EQ-5D-5L index values, more impairment in pulmonary functions, and more frequent radiological abnormalities than patients without PE. Symptoms of anxiety, depression, cognitive failure, and posttraumatic stress disorder did not differ between the 2 groups. In model 2, PE was associated with lower EQ-5D-5L index and lower DLCO%. After additionally adjusting for intensive care unit admission, the association between PE and lower EQ-5D-5L index (mean difference = -0.069, [95% CI, -0.12 to -0.017]) remained but not between PE and DLCO%.

CONCLUSION

Our findings suggest that PE in COVID-19 patients is associated with reduced health-related quality of life at 3 months after hospitalization. While PE may be a marker of COVID-19 severity, its presence during hospitalization could indicate potential long-term health issues, which may be considered during follow-up care.

摘要

背景

新冠病毒疾病(COVID-19)患者经常发生肺栓塞(PE),但其长期后果仍不确定。

目的

评估COVID-19患者发生的肺栓塞对住院3个月后健康结局的影响。

方法

在这项多中心横断面研究中,我们汇总了现有数据库中的数据,以评估肺栓塞对住院3个月后健康结局的影响。我们评估了:1)与健康相关的生活质量问卷(5级欧洲五维健康量表[EQ-5D-5L]问卷)、焦虑、抑郁、认知功能障碍和创伤后应激障碍问卷;2)肺功能测试(肺一氧化碳弥散量[DLCO]和肺量计);以及3)放射学异常。我们建立了3个模型来评估肺栓塞与EQ-5D-5L指数以及预测的DLCO百分比(DLCO%)之间的关联:一个粗模型(模型1),对年龄、性别和合并症的存在进行了调整(模型2),模型2还对重症监护病房入住情况进行了调整(模型3)。

结果

我们纳入了465例因COVID-19住院的患者,其中102例(21.9%)在住院期间发生了肺栓塞。与未发生肺栓塞的患者相比,发生肺栓塞的患者EQ-5D-5L指数值更低,肺功能损害更严重,放射学异常更频繁。两组之间焦虑、抑郁、认知功能障碍和创伤后应激障碍的症状没有差异。在模型2中,肺栓塞与较低的EQ-5D-5L指数和较低的DLCO%相关。在进一步对重症监护病房入住情况进行调整后,肺栓塞与较低的EQ-5D-5L指数之间的关联仍然存在(平均差异=-0.069,[95%CI,-0.12至-0.017]),但肺栓塞与DLCO%之间的关联不再存在。

结论

我们的研究结果表明,COVID-19患者发生的肺栓塞与住院3个月后与健康相关的生活质量下降有关。虽然肺栓塞可能是COVID-19严重程度的一个标志,但其在住院期间的出现可能表明潜在的长期健康问题,在后续护理中可能需要考虑这些问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/141b/11980619/4e6c56218e44/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验